ORIGINAL ARTICLE Frequent MUGA testing in a myeloma patient: A case-based ethics discussion a b c,d Sabha Bhatti, MD, Robert C. Hendel, MD, Juan Lopez-Mattei, MD, e f Ronald G. Schwartz, MD, MS, Gilbert Raff, MD, and Andrew J. Einstein, MD, g,h PhD Division of Cardiovascular Medicine, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR Departments of Medicine and Radiology, University of Miami Miller School of Medicine, Miami, FL Division of Diagnostic Imaging, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX Cardiology Division, Department of Medicine, Nuclear Medicine Division, Department of Imaging Sciences, University of Rochester, Rochester, NY Department of Cardiovascular Medicine, William Beaumont Hospital, Royal Oak, MI Department of Medicine, Division of Cardiology, Columbia University Medical Center and New York-Presbyterian Hospital, New York, NY Department of Radiology, Columbia University Medical Center and New York-Presbyterian Hospital, New York, NY Received Apr 27, 2016; accepted May 3, 2016 doi:10.1007/s12350-016-0540-1 CASE PRESENTATION regimen, which includes the mitogen-activated protein kinase kinase inhibitor trametinib, a potentially car- A 51-year-old African-American male with a his- diotoxic
Journal of Nuclear Cardiology – Springer Journals
Published: Jun 6, 2016
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera